FDA NDC Directory · JSON-LD · Markdown

Acamprosate Calcium

NDC 60687-121 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerAmerican Health Packaging
Marketing categoryAbbreviated NDA (generic) · App ANDA202229
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsACAMPROSATE CALCIUM (333 mg/1)
Marketing started20151027
Package count1

External sources

Source: openFDA. Public-domain (CC0).